Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chris Jones

Showing results (271-280 of 333) with videos related to

Pageof 34
Sort By:
Journal of Chemical and Engineering Data|June 18, 2025
Achieving Reproducibility and Replicability of Molecular Dynamics and Monte Carlo Simulations Using the Molecular Simulation Design Framework (MoSDeF)Nicholas C Craven, Ramanish Singh, Co D Quach, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 11, 2021
Molecular landscape of IDH-mutant primary astrocytoma Grade IV/glioblastomasQueenie Hoi-Wing Wong, Kay Ka-Wai Li, Wei-Wei Wang, et al.
Scientific Reports|December 22, 2025
Navitoclax acts synergistically with irradiation to induce apoptosis in preclinical models of H3K27M-altered diffuse midline gliomaAshley Vardon, Scott Haston, Hiba Hamdi, et al.
Acta Neuropathologica|May 19, 2022
Recurrent ACVR1 mutations in posterior fossa ependymomaDrew Pratt, Calixto-Hope G Lucas, Pavalan Panneer Selvam, et al.
Journal of Neuro-Oncology|January 18, 2017
The international diffuse intrinsic pontine glioma registry: an infrastructure to accelerate collaborative research for an orphan diseaseJoshua Baugh, Ute Bartels, James Leach, et al.
Neuro-Oncology|December 29, 2021
Dual IGF1R/IR inhibitors in combination with GD2-CAR T-cells display a potent anti-tumor activity in diffuse midline glioma H3K27M-mutantEmmanuel de Billy, Marsha Pellegrino, Domenico Orlando, et al.
Neuro-Oncology|June 11, 2016
Pediatric high-grade glioma: biologically and clinically in need of new thinkingChris Jones, Matthias A Karajannis, David T W Jones, et al.
Cancer Discovery|September 23, 2021
Repurposing Vandetanib plus Everolimus for the Treatment of <i>ACVR1</i>-Mutant Diffuse Intrinsic Pontine GliomaDiana M Carvalho, Peter J Richardson, Nagore Olaciregui, et al.
Cancer Cell|May 16, 2018
Molecular, Pathological, Radiological, and Immune Profiling of Non-brainstem Pediatric High-Grade Glioma from the HERBY Phase II Randomized TrialAlan Mackay, Anna Burford, Valeria Molinari, et al.
Neuro-Oncology|November 1, 2020
A subset of pediatric-type thalamic gliomas share a distinct DNA methylation profile, H3K27me3 loss and frequent alteration of EGFRPhilipp Sievers, Martin Sill, Daniel Schrimpf, et al.
Pageof 34

Showing results (271-280 of 333) with videos related to

Sort By:
Pageof 34
Journal of Chemical and Engineering Data|June 18, 2025
Achieving Reproducibility and Replicability of Molecular Dynamics and Monte Carlo Simulations Using the Molecular Simulation Design Framework (MoSDeF)Nicholas C Craven, Ramanish Singh, Co D Quach, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 11, 2021
Molecular landscape of IDH-mutant primary astrocytoma Grade IV/glioblastomasQueenie Hoi-Wing Wong, Kay Ka-Wai Li, Wei-Wei Wang, et al.
Scientific Reports|December 22, 2025
Navitoclax acts synergistically with irradiation to induce apoptosis in preclinical models of H3K27M-altered diffuse midline gliomaAshley Vardon, Scott Haston, Hiba Hamdi, et al.
Acta Neuropathologica|May 19, 2022
Recurrent ACVR1 mutations in posterior fossa ependymomaDrew Pratt, Calixto-Hope G Lucas, Pavalan Panneer Selvam, et al.
Journal of Neuro-Oncology|January 18, 2017
The international diffuse intrinsic pontine glioma registry: an infrastructure to accelerate collaborative research for an orphan diseaseJoshua Baugh, Ute Bartels, James Leach, et al.
Neuro-Oncology|December 29, 2021
Dual IGF1R/IR inhibitors in combination with GD2-CAR T-cells display a potent anti-tumor activity in diffuse midline glioma H3K27M-mutantEmmanuel de Billy, Marsha Pellegrino, Domenico Orlando, et al.
Neuro-Oncology|June 11, 2016
Pediatric high-grade glioma: biologically and clinically in need of new thinkingChris Jones, Matthias A Karajannis, David T W Jones, et al.
Cancer Discovery|September 23, 2021
Repurposing Vandetanib plus Everolimus for the Treatment of <i>ACVR1</i>-Mutant Diffuse Intrinsic Pontine GliomaDiana M Carvalho, Peter J Richardson, Nagore Olaciregui, et al.
Cancer Cell|May 16, 2018
Molecular, Pathological, Radiological, and Immune Profiling of Non-brainstem Pediatric High-Grade Glioma from the HERBY Phase II Randomized TrialAlan Mackay, Anna Burford, Valeria Molinari, et al.
Neuro-Oncology|November 1, 2020
A subset of pediatric-type thalamic gliomas share a distinct DNA methylation profile, H3K27me3 loss and frequent alteration of EGFRPhilipp Sievers, Martin Sill, Daniel Schrimpf, et al.
Pageof 34